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Abstract
Background: Heart failure (HF) is expected to be highly prevalent in nursing home residents, but precise figures
are scarce. The aim of this study was to determine the prevalence of HF in nursing home residents and to get
insight in the clinical characteristics of residents with HF.
Methods: The study followed a multi-centre cross-sectional design.
Nursing home residents (n = 501) in the southern part of the Netherlands aged over 65 years and receiving long-term
somatic or psychogeriatric care were included in the study. The diagnosis of HF and related characteristics were based
on data collected from actual clinical examinations (including history, physical examination, ECG, cardiac markers and
echocardiography), patient records and questionnaires. A panel of two cardiologists and a geriatrician ultimately
judged the data to diagnose HF.
Results: The overall prevalence of HF in nursing home residents was 33 %, of which 52 % had HF with preserved
ejection fraction. The symptoms dyspnoea and oedema and a cardiac history were more common in residents with
HF. Diabetes mellitus, chronic obstructive pulmonary disease (COPD) were also more prevalent in those with HF.
Residents with HF had a higher score on the Mini Mental State Examination. 54 % of those with HF where not
known before, and in 31 % with a history of HF, this diagnosis was not confirmed by the expert panel.
Conclusion: This study shows that HF is highly prevalent in nursing home residents with many unknown or falsely
diagnosed with HF. Equal number of HF patients had reduced and preserved left-ventricular ejection fraction.
Trial registration: The Netherlands National Trial Register NTR2663 (27-12-2010)
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Background
In Western countries, heart failure (HF) is common in
older people. The prevalence of HF increases up to
17.4 % at the age of 85 years and more [1]. It is a grow-
ing problem as the population ages and survival rates
after cardiovascular events increase [2]. In addition,
there is a longer exposure to risk factors for HF and
age-related changes [3]. Various factors such as older
age, hypertension, diabetes mellitus (DM), obesity and
coronary artery disease (CAD) have been described as
risk factors for developing HF [4, 5].
Early diagnosis and treatment of HF may prevent
progression and lead to improvement of symptoms and
quality of life [6, 7], which are especially important in
the care of nursing home residents. These residents can
be described as old and considerably disabled persons,
with either chronic somatic diseases or progressive de-
mentia beyond the range of home care services [8]. The
diagnosis of HF in nursing home residents is however
challenging, due to atypical signs and symptoms, cogni-
tive impairment, immobility, polypharmacy and misin-
terpretation of symptoms due to co-morbidities [9, 10].
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Importantly, these residents often do not undergo proper
diagnostics as recommended by the guidelines [11]. As a
consequence, the prevalence of HF in such residents may
be significantly underestimated, but also overestimated
due to misinterpretation of symptoms corresponding to
comorbidities. A systematic review by Daamen et al.
showed that the prevalence of HF in nursing home resi-
dents is estimated to be 15–25 % [12]. The diagnosis of
HF was, however, based on information derived from
medical records only in all but one study included. In
this study by Butler et al., the diagnosis of HF was made
after a clinical examination, resulting in an HF preva-
lence as high as 45 % [13]. However, the prevalence in
UK long-term care facilities was recently reported to be
much lower when also using echocardiography (i.e.
23 %) [14]. Thus, there is significant uncertainty regarding
the proper diagnosis of HF in nursing home residents.
The aim of this study was, therefore, to determine the
prevalence and clinical characteristics of HF in Dutch
nursing home residents, based on an onsite comprehen-
sive HF assessment, including not only medical history,
medication and clinical assessment, but also ECG, echo-
cardiography and biomarkers, and final diagnosis was
made by an expert panel.
Methods
This study followed a multi-centre cross-sectional de-
sign as previously published [15]. The study protocol
complied with the declaration of Helsinki and has been
granted approval from the Medical Ethics Committee
of Maastricht University/Academic Hospital Maastricht
(NL33281.068.10/MEC10-3-074). The study has been
registered in the Netherlands National Trial Register
(NTR2663).
Setting and participants
In the southern parts of the Netherlands, long-term care
is covered by five organizations providing nursing home
care, with an overall number of approximately 4.500
nursing home residents. Nursing home care in the
Netherlands is provided by teams of registered nurses,
nurse assistants, paramedical professionals and nursing
home physicians, who are employed by the nursing
homes themselves [16]. The types of care offered by
nursing homes include long-term care (somatic or psy-
chogeriatric), rehabilitation, respite care, palliative (or
hospice) care, consultation and advice and crisis inter-
vention [8].
Nursing home residents at 28 locations allocated to
these five long-term care organizations were asked to par-
ticipate in the study (n = 1 920). To complete the study
within the specified time period (January 2011 to June
2013) and for practical and logistical reasons, nursing
home residents living in the facilities with the highest
number of residents were first recruited within each care
home organization. The number of locations involved per
organization differed from 3 to 8. Residents were eligible
if they received chronic somatic care or psychogeriatric
care and were over 65 years of age. Residents who re-
ceived palliative care or were admitted for short-term re-
habilitation (staying less than 2 months) were excluded.
Informed written consent was obtained from the residents
themselves or from their legal representatives in the case
of psychogeriatric disorder, or residents with aphasia.
Based on our systematic review, the expected preva-
lence of HF was 20 % with a range of 15–45 % [12]. For
the calculation of the required sample size, it seemed
reasonable to assume that the estimated prevalence of
HF in nursing home residents would be within the
range p = 0.20 to p = 0.40 with a confidence interval
width of 25 % of the estimated prevalence. Accordingly,
368 (if p = 0.40) to 983 residents (if p = 0.20) [15]
should be included in the study for sufficient power as
described [15].
Measurements and materials
Demographic data and clinical characteristics
Data regarding general and clinical characteristics were
gathered for all participating residents. These included
age, gender and symptoms and signs of HF (dyspnoea,
orthopnoea, palpitations, paroxysmal nocturnal dyspnoea
(PND), fatigue, increased weight, pulse rate, blood pres-
sure, increased jugular venous pressure, hepatojugular
reflux, right ventricular pulsations, hepatic pulsations,
hepatomegaly, oedema, palpable apex, displacement of the
apex, third heart sound, murmur, pulmonary rales, pleural
effusion). Moreover, information regarding cardiac history
(hypertension, myocardial infarction, arrhythmia, CAD,
valvular heart disease, coronary bypass graft, pacemaker,
pre-existing heart failure), co-morbidity, cardiovascular
risk factors (Body Mass Index (BMI), hypercholesterol-
emia, DM and smoking) and medication (cardiac and
non-cardiac medication) were collected. Patients under-
went a Mini Mental State Examination (MMSE), blood
sampling, a standard 12-lead electrocardiogram (ECG)
and an echocardiogram. Doppler-echocardiography was
performed according to current standards from paraster-
nal, apical and epigastric views [17].
Study procedure of the heart failure assessment
First, a nursing home physician (NHP) assessed medical
history and performed physical examination. Before the
start of the study, this NHP (3–4 per organization) had
received a refresher course on diagnosing HF and per-
forming a structured physical examination. The training
included a review of signs and symptoms of HF followed
by bedside teaching (3 h), a lecture on ECG findings in
relation to HF (2 h) and a visit to the outpatient HF
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clinic of the Maastricht University Medical Centre (3 h).
Two research nurses and an NHP/researcher were re-
sponsible for recording the ECGs, collecting the blood
samples, gathering data from the medical records and
filling in the questionnaires. Qualified (fellow) cardiolo-
gists recorded an echocardiogram on site. The entire
assessment was carried out on site in the participating
nursing homes with a mean time span of four weeks to
complete data collection per resident.
The actual history and physical examination were re-
corded on a client record file developed for this study.
Somatic residents answered the history-related questions
and for psychogeriatric residents, these questions were
answered by the nurses responsible for their daily care
or the main family caregiver of the resident. N-terminal
of the prohormone brain natriuretic peptide (NT-pro
BNP), haemoglobin and serum creatinine concentrations
were analysed at the clinical chemistry laboratory of the
Maastricht University Medical Centre on an Elecsys 2010
(Roche Diagnostics, Mannheim, Germany). A standard
12-lead ECG was made using the Cardiovit AT-10 plus
(Schiller, Switzerland). The following (possibly HF-related)
ECG findings were recorded: sinus tachycardia (heart
rate > 100 beats/min), sinus bradycardia (heart rate < 60
beats/min), pathological Q-waves, atrial fibrillation, ven-
tricular arrhythmia, different degrees of AV-block, low
voltage of the QRS complexes (<5 mm in the frontal plan),
QRS widening (>0.12 ms) due to right bundle branch
block, left bundle branch block or non-specific widening
and left (LV) and/or right ventricular (RV) hypertrophy
[18]. The echocardiogram was performed using a Philips
CX50 Compact Xtreme Ultrasound System (Philips, the
Netherlands). The following parameters were measured
using standard views (Lang); LV end-diastolic and end-
systolic diameter, LV wall thickness, LV function indica-
tors such as fractional shortening and LV ejection fraction,
diastolic function variables such as E/A and E/E’ ratio, left
atrial size, valvular structure and function, tricuspid re-
gurgitation velocity peak as an indicator of RV systolic
pressure, RV dilatation and/or hypertrophy and dys-
function and vena cava inferior width and respiratory
variation as a marker of venous overload. A LV ejection
fraction of ≥ 50 % was regarded as preserved ejection
fraction [19].
Diagnosis of heart failure
An expert team of two cardiologists and a geriatrician
were responsible for the final diagnosis of HF using all
data collected by the NHP, research nurse and (fellow)
cardiologist, based on the current ESC guidelines [20].
1. Signs and symptoms of HF
2. Presence of structural or functional cardiac
abnormalities.
The members of the expert team judged all files inde-
pendently. First the data were judged on the presence of
signs and symptoms. Subsequently, the measurements of
the echocardiography and the ECG were used to assess
functional and/or structural cardiac abnormalities, com-
patible with the diagnosis of HF. In the absence of
current signs and symptoms, medical history and medi-
cation provided important information to make the diag-
nosis of HF. In residents without an echocardiogram or
in the case of uncertainty regarding the diagnosis, the
NT-pro BNP value, ECG findings, medical history and
medication (in that order) were considered for the final
diagnosis.
When there was mutual agreement on the diagnosis,
the file was closed. All files with disagreement were dis-
cussed in the presence of all three members of the expert
team to reach a consensus on the final diagnosis.
Statistical analysis
Statistical analyses were performed using IBM SPSS
statistics software version 20 and included descriptive
frequency distributions for all variables. Differences be-
tween groups were tested using Student’s t-tests or ana-
lysis of variance (ANOVA) for continuous variables and
Chi-square test (cross-table analysis) and multivariable
logistic regression analysis for discrete variables, re-
spectively, with a level of significance of p < 0.05 for all
variables. The selection of variables included in the
multivariable logistic regression analysis was based on
the literature and expert opinion. These variables were
gender, CAD, BMI, DM, chronic obstructive pulmonary
disease (COPD), haemoglobin, creatinine, heart rate,
systolic blood pressure, pre-existing HF, arrhythmia,
valvular heart disease, [21, 22]. To avoid circular rea-
soning the variables dyspnoea, signals of right sided HF
and NT-pro BNP were not added to the model, because
these were used to diagnose HF.
Results
Study sample
Of the residents fulfilling the inclusion criteria, 27 % of
those or their legal representatives agreed to participate.
Main reasons for not participating included that resi-
dents considered themselves too old or believed that the
investigations were too burdensome. The expert team
eventually assessed 501 client record files and decided
on the diagnosis of HF. HF assessment (medical history,
physical examination, blood sampling, ECG and echo)
was completed for 87 % of the participating residents
(see Fig. 1 for further details). Missing blood samples oc-
curred because of the inability to puncture the vein.
Some ECG’s could not be made due to resistance (n = 3)
and extreme tremor in the limbs (n = 2). Missing out-
comes of echocardiography were mainly caused by poor
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image quality due to e.g. obesity and in case of COPD.
In a minority of cases (n = 10) psychogeriatric residents
resisted against the echocardiography.
The demographic characteristics, age, gender and ward
type showed no clinical significance differences for both
participants and non-participants (see Table 1).
The prevalence of heart failure
The prevalence of HF in nursing home residents was
33 % with a 95 % confidence interval of 29 to 37 %, of
which 54 % were not previously known (Fig. 2). HF was
more often diagnosed in the somatic group than in psy-
chogeriatric residents. The prevalence was practically
similar in men and women. Reduced LV ejection fraction
was present in 64 and preserved ejection fraction in 70
cases. Asymptomatic systolic dysfunction of the left ven-
tricle (LVEF < 50 without symptoms, stage B) was found
in 27 residents (see also Table 2) [20].
HF was recorded in the medical history of 112 resi-
dents. The diagnosis of HF was rejected in 31 % of those
residents. Figure 2 shows an overview of the prevalence
of HF compared with HF previously recorded in medical
files.
Clinical characteristics
As depicted in Table 3, residents with HF were older,
more likely to have complaints of orthopnoea and palpi-
tations, more often had a cardiac history of myocardial




- < 65 years (N=56)
- Receiving palliative care
(N=24)
- No legal representative to 
obtain informed consent
(N=21)
Residents eligible to 
participate in the study
N= 1819










- Stopped for personal 
reasons (N=3)
- Died before HF 
assessment started 
(N=7)








- No bloodsample (n=6)
- No ECG (n= 5)
- No echo (n= 50)
a combination of 2 missing 
items was present in 4 
residents.(1x blood sample 
and ECG, 2x ECG and Echo, 
1x Blood and echo)
Fig. 1 Flow chart of residents participation
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ischemia, myocardial infarction and arrhythmia and
more often displayed signs of an increased jugular ven-
ous pressure, pulsations of the right ventricle, oedema,
murmurs and pulmonary rales. A higher number of
nursing home residents with HF had diabetes mellitus,
COPD and/or less cognitive disorders. However, none of
these factors were sufficiently sensitive or specific for
diagnosing or excluding heart failure. Regarding the car-
diac risk factors (hypercholesterolemia, smoking and
BMI), there were no differences between the study
groups with and without HF.
The independent predictors of prevalent HF entered in
the multivariable logistic regression model are presented
in Table 4. The non-significant variables (p > 0.05) were
removed stepwise using the backward procedure. The
final model showed that the variables, CAD, arrhythmia,
age, creatinine and HF in history being significant in uni-
variate analysis were independent factors associated with
the presence of HF.
Discussion
In this study, the prevalence of HF was 33 % for all par-
ticipating nursing home residents, of which more than
half were previously undiagnosed and a previous diagno-
sis of HF was rejected in almost one third. HFpEF and
HFrEF were equally prevalent. Therefore, the hypothesis
that HF is highly prevalent in nursing home residents is
confirmed, and the prevalence was clearly higher than
among older persons in the general population [1].
The prevalence of 45 % found in a study by Butler
et al.[13] in which HF was diagnosed in nursing home
residents after physical examination by a geriatrician, is
higher than in our study. However, the limitations of
that study were the lack of a clear description of HF
and the lack of further diagnostics such as an echocardio-
gram as recommended by the guidelines [20]. Therefore,
the presence of HF may be overestimated, which is in line
with other studies of a similar population by Hancock
et al.[14] and Barents et al. [23] where the prevalence
of HF was much lower (i.e. 23 %). The HF assessment
and definition of HF in these studies were similar to
our study. The demographic and clinical characteristics
of the residents were also comparable to our study.
There is no obvious explanation as to why the preva-
lence rate in our study was somewhat higher. The dif-
ference between the studies of Hancock et al. [14] and
Barents et al. [23] and our study is the confirmation of
the diagnosis of HF by an expert team of two cardiologists
and a geriatrician. In their studies, there were individual
decisions by two cardiologists and no panel discussions.
Residents with HF had less cognitive disorders; a result
which is not in line with studies in the literature where pa-
tients with HF suffer more often from cognitive disorders
[24, 25]. This might be explained by the fact that there is a









HF not known before
N= 89




Fig. 2 Prevalence of HF compared with HF previously recorded in medical files
Table 1 Basis characteristics of participants and non-participants
Characteristics Participants (n = 513) Non-participants (n = 1306)*
Age (years) 65–74 69 (14 %) 116 (11 %)
75–84 238 (46 %) 436 (43 %)
85+ 206 (40 %) 464 (46 %)
Mean (SD, range) 82 (7, 65–100) 83 (7, 65–108)
Gender Male 184 (36 %) 376 (29 %)
Female 329 (64 %) 930 (71 %)
Ward Psychogeriatric care 336 (65 %) 889 (68 %)
Somatic care 177 (35 %) 417 (32 %)
*Age available for n = 1016 non-participants
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are a specific group of older persons, where a high num-
ber suffers from cognitive disorders as the primary diag-
nosis. However analysis of the MMSE score in the
subgroup of somatic residents still shows a higher MMSE
score in residents with HF.
In the study by Hanock et al. [14], more patients (i.e.
app. two-third) with HFpEF were observed as com-
pared to our study. HFpEF was equally common as
HFrEF in our study, and as expected, more prevalent in
women [4]. In large cohorts of the general population,
the frequency of HFrEF versus HFpEF was also the
same with approximately half having reduced and half
having preserved LVEF [26, 27], although average age
was lower than in our cohort of nursing home residents
(i.e. app 75 years). Asymptomatic left ventricular sys-
tolic dysfunction was additionally found in 10 % of the
residents in our study. Taken together, there was a
substantial number of residents with reduced LVEF, i.e.
approximately one fourth of all residents investigated in
this study. Compared with the study by Hancock
et al.[14], this is a higher percentage of residents with
reduced LVEF and could explain the difference in the
prevalence of HF. HFrEF is better defined than HFpEF
and particularly asymptomatic diastolic dysfunction in
such an elderly population is difficult to determine.
Therefore, direct comparison of patients with reduced
LVEF between different cohorts may be more reliable
despite some inaccuracy in measurement of LVEF by
echocardiography [28]. Nevertheless, it obviously re-
mains to be determined how many of the patients with
asymptomatic reduced LVEF will develop signs and
symptoms of HF over time.
Multivariable analysis showed that factors such as
arrhythmia, CAD, age, a history of pre-existing HF were
associated with the presence of HF. Interestingly, there
was no association found with gender, which may be a
risk factor for the development of HF in the general
population [29]. There were no other studies in nursing
home residents that investigated risk factors for preva-
lent HF in multivariable analysis. Thus, the specific pat-
tern of risk factors in residents of nursing homes needs
to be confirmed in future trial, in particular because they
differ somewhat to what is described in other cohorts.
Furthermore, the diagnosis HF was not known in
more than half of those having HF and a previous diag-
nosis of HF was not confirmed by the expert team in
one third of all cases. These findings indicate an im-
portant problem as a significant number of residents
obviously might not be treated correctly. This could be
of significant impact to residents of nursing homes as it
can be expected that symptoms are not adequately
recognised and treated in a substantial number of pa-
tients. Although not prospectively investigated by ran-
domised treatment trials in this population, this may
have important impact on well-being and quality of life.
Moreover, it implies a challenge to improve the diag-
nostic process of HF in nursing homes residents. The
implementation of the structured procedure used by
the expert team may improve the diagnostic process
significantly. This includes echocardiography using mo-
bile devices in residents suspected to suffer from HF.
The clinical features identified in this study to be ac-
companied with increased risk of prevalent HF may
help to detect such patients that should undergo such
structured work-up.
The strength of the present study is the thorough
method of data collection using an on-site integral
examination of each resident. On the other hand, the
participation rate was not as high as anticipated (27 %).
A consideration here is that legal representatives often
do not want to decide for participation on behalf of the
residents, which explains the lower participation rate of
psychogeriatric patients. Our findings are in line with a
study conducted by Barnes [30] on HF in the elderly,
where only 30 % of patients agreed to participate. Still,
residents included did not differ in a clinical meaning-
ful way from those that did not agree to participate.
Therefore, it is likely that the results of this study are
representative for our nursing home population in the
South of the Netherlands. A 10 % missing echo values
can be seen as a limitation in this study. This may re-
sult in misdiagnosis in some patients and importantly,
lack of information on potential underlying causes of
heart failure and left-ventricular ejection fraction. This may
negatively effect quality of treatment in these patients.
However, in routine clinical care, echocardiography cannot
Table 2 Presence of heart failure in nursing home residents
Variabele HF absent HF present (95 %-CI) of perc. HF HFrEFa HFpEFa Asymptomatic HF with rEFb
Total 335 (67 %) 166 (33 %) (29 %, 37 %) 64 (48 %) 70 (52 %) 27 (10 %)
Gender Male 118 (66 %) 61 (34 %) (30 %,38 %) 29 (58 %) 21 (42 %) 12 (44 %)
Female 217 (67 %) 105 (33 %) (29 %,37 %) 35 (42 %) 49 (58 %) 15 (56 %)
Ward Psychogeriatric care 227 (70 %) 99 (30 %) (26 %,34 %) 36 (45 %) 44 (55 %) 19 (70 %)
Somatic care 108 (62 %) 67 (38 %) (34 %,42 %) 28 (52 %) 26 (48 %) 8 (30 %)
HFrEF heart failure with reduced ejection fraction, HFpEF heart failure with preserved ejection fraction, rEF reduced ejection fraction
aEcho data about left ventricular ejection fraction (LVEF) available for 134 of the 166 residents with HF
bEcho data about LVEF available for 271 of the 335 residents without HF
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Table 3 Demographic and clinical characteristics
Variables Total HF- HF+ p-value
N = 501 N = 335 N = 166
Age (years) mean (SD) 82 (7) 81 (7) 84 (6) <.001
Gender, male n (%) 179 (36) 118 (35) 61 (37) 0.738
psychogeriatric n (%) 326 (65) 227 (68) 99 (60) 0.073
Symptoms
NYHA class n (%) n = 494
1 301 (60) 235 (70) 66 (40) <.001
2 108 (22) 55 (16) 53 (33) <.001
3 57 (11) 26 (8) 31 (19) 0.001
4 28 (6) 15 (5) 13 (8) 0.203
Orthopnoea n (%) n = 486 62 (12) 29 (9) 33 (20) 0.001
Palpitations n (%) n = 484 70 (14) 27 (8) 43 (26) <.001
PND n (%) n = 486 40 (8) 22 (7) 18 (11) 0.033
Fatigue n (%) n = 492 183 (37) 113 (34) 70 (42) 0.178
Weight gain n (%) n = 480 97 (19) 69 (21) 28 (17) 0.522
Physical examination
Anemic n (%) n = 500 28 (6) 17 (5) 11 (7) 0.609
Cyanotic n (%) n = 500 1 (0,2) 1 (0,3) 1 (0,6) 0.284
Dyspnoea n (%) n = 497 82 (16) 43 (13) 39 (24) 0.004
Pulse rate mean (SD) n = 500 73 (14) 72 (12) 74 (17) 0.069
Systolic blood pressure mean (SD) n = 498 139 (26) 141 (26) 136 (25) 0.030
Diastolic blood pressure mean (SD) n = 498 75 (14) 75 (13) 74 15) 0.219
Increased VJ pressure n (%) n = 481 128 (26) 66 (20) 166 (37) <.001
HPR n (%) n = 468 26 (5) 16 (5) 10 (6) 0.570
Pulsations RV n (%) 61 (12) 30 (9) 31 (19) 0.002
Pulsations liver n (%) 18 (4) 11 (3) 7 (4) 0.597
Hepatomegaly n (%) n = 484 35 (7) 20 (6) 15 (9) 0.298
Oedema n (%) n = 500 275 (55) 166 (50) 109 (66) <.001
Ictus palpable n (%) n = 494 158 (32) 102 (30) 56 (34) 0.628
Third heart sound n (%) n = 467 17 (3) 10 (3) 7 (4) 0.746
Murmur n (%) n = 473 185 (37) 110 (33) 75 (45) 0.019
Irregular heartbeats n (%) n = 498 153 (31) 66 (20) 87 (52) <.001
Rales n (%) n = 459 151 (30) 75 (22) 76 (46) <.001
Pleural effusion n (%) n = 412 34 (7) 15 (5) 19 (11) 0.008
Cardiac history
Hypertension n (%) 236 (47) 146 (44) 90 (54) 0.025
Myocardial infarction n (%) n = 490 81 (16) 37 (11) 44 (27) <.001
Arrhythmia n (%) n = 476 132 (28) 54 (17) 78 (50) <.001
Coronary ischemia n (%) n = 490 113 (23) 57 (17) 56 (34) <.001
Valvular heart disease n (%) n = 495 38 (8) 13 (4) 25 (15) <.001
Coronary bypass graft n (%) n = 496 40 (8) 17 (5) 23 (14) 0.003
Pace maker n (%) n = 493 19 (4) 8 (2,4) 11 (7) 0.059
Heart failure in history n (%) 112 (22) 35 (10) 77 (46) <.001
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be performed in all subjects due to exactly the same rea-
sons also found in our cohort.
Moreover, we did not investigate to what extent treat-
ment would have changed based on more accurate diag-
nosis and the impact on the patients’ well-being is
unknown. This is particularly true since the large treat-
ment trials that are the basis for the treatment recom-
mendations did not include the population of our study.
Still, guideline recommendations are independent of pa-
tient’s age. Therefore, the diagnostic approach we used
would at least result in treatment which is better follow-
ing current guidelines. Finally, we included residents in
one region only and results might be different in other
countries and may depend on the structure of health
care in each country. Therefore, it is important to con-
duct such studies in different countries as results in this
regard are still very limited.
Conclusion
HF is highly prevalent in nursing home residents with
many unknown or falsely diagnosed with HF. Equal
number of HF patients had reduced and preserved left-
ventricular ejection fraction.
Table 3 Demographic and clinical characteristics (Continued)
Blood sample
NT- pro BNP mean (IQR) n = 493 nmol/L 138 (3–4130) 61 (3–3427) 292 (13–4130) <.001
Creatinine μmol/l mean (SD) n = 493 88 (51) 82 (44) 99 (61) <.001
Haemoglobin mmol/l mean (SD) n = 467 8,0 (0,90) 8,1 (0,87) 7,8 (0,93) 0.002
Co-morbidity
Diabetes mellitus n (%) 107 (21) 63 (19) 44 26) 0.048
COPD n (%) 83 (17) 45 (13) 38 (23) 0.007
CVA n (%) 207 (41) 131 (39) 76 (46) 0.153
Cardiac risk factors
BMI mean (SD) n = 488 25 (5) 25 (5) 26 (5) 0,224
Hypercholesterolemia n (%) n = 444 130 (26) 88 (26) 42 (25) 0.209
Smoking n (%) n = 492 68 (14) 46 (14) 22 13) 0.358
Cognitive function
MMSE mean (SD) n = 477 14 (9) 13 (9) 16 (8) 0.011
NYHA New York Heart Association, PND paroxysmal nocturnal dyspnoea, HPR hepatojugular reflux, RV right ventricle, NT-proBNP N-terminal of prohormone brain
natriuretic peptide, COPD chronic obstructive pulmonary disease, CVA cerebrovascular accidents, BMI body mass index, MMSE mini mental state examination
Table 4 Multivariable logistic regression analysis
Final model
Variable OR Ratio 95 %-CI p-value OR 95 %-CI p-value
Gender 0.98 0.58 1.65 0.92
Coronary artery disease 2.24 1.36 3.68 .002 2.10 1.29 3.40 0.003
Body Mass Index (kg/m2) 1.03 0.98 1.08 0.29
Diabetes mellitus 1.09 0.62 1.91 0.77
COPD 1.15 0.63 2.10 0.64
Haemoglobin (mmol/l) 0.84 0.65 1.11 0.22
Arrhythmia 3.80 2.32 6.23 <.001 4.12 2.55 6.65 <.001
Age (years) 1.08 1.04 1.12 <.001 1.07 1.04 1.11 <.001
Creatinine (μmol/l) 1.01 1.00 1.01 0.06 1.01 1.00 1.01 0.026
Heart failure in history 5.46 3.23 9.24 <.001 5.97 3.58 9.95 <.001
Valvular heart disease 0.92 0.72 1.18 0.52
Heart rate (beats/min) 1.01 0.99 1.03 0.26
Systolic blood pressure (mmHg) 1.00 0.99 1.01 0.43
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